Earnings Call
AbbVie Inc. (ABBV) Q3 2025 Earnings Call Transcript
Presentations
company representative·Additional Participants
company representative
Elizabeth Shea - Senior Vice President of Investor Relations
Robert Michael - CEO & Chairman of the Board
Jeffrey Stewart - Executive VP & Chief Commercial Officer
Roopal Thakkar - Executive VP of Research and Development & Chief Scientific Officer
Scott Reents - Executive VP & CFO
Additional Participants
Terence Flynn - Morgan Stanley, Research Division
Christopher Schott - JPMorgan Chase & Co, Research Division
Vamil Divan - Guggenheim Securities, LLC, Research Division
Matthew Phipps - William Blair & Company L.L.C., Research Division
David Amsellem - Piper Sandler & Co., Research Division
David Risinger - Leerink Partners LLC, Research Division
Steve Scala - TD Cowen, Research Division
Simon Baker - Rothschild & Co Redburn, Research Division
Luisa Hector - Joh. Berenberg, Gossler & Co. KG, Research Division
Mohit Bansal - Wells Fargo Securities, LLC, Research Division
Geoffrey Meacham - Citigroup Inc., Research Division
Courtney Breen - Sanford C. Bernstein & Co., LLC., Research Division
Asad Haider - Goldman Sachs Group, Inc., Research Division
Operator
Good morning, and thank you for standing by. Welcome to the AbbVie Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Today's call is also being recorded. If you have any objections, you may disconnect at this time. I would now like to introduce Ms. Liz Shea, Senior Vice President of Investor Relations. Thank you. You may begin.
Elizabeth Shea
Good morning, and thanks for joining us. Also on the call with me today are Rob Michael, Chairman and Chief Executive Officer; Jeff Stewart, Executive Vice President, Chief Commercial Officer; Roopal Thakkar, Executive Vice President, Research and Development, Chief Scientific Officer; and Scott Reents, Executive Vice President, Chief Financial Officer.
Before we get started, I'll note that some statements we make today may be considered forward-looking statements based on
Before we get started, I'll note that some statements we make today may be considered forward-looking statements based on